Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 21319-53-9 | MDL No. : | MFCD00756921 |
Formula : | C13H17NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FEUCBQVXYVZGCM-UHFFFAOYSA-N |
M.W : | 219.28 | Pubchem ID : | 2841641 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 66.72 |
TPSA : | 40.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.67 cm/s |
Log Po/w (iLOGP) : | 2.08 |
Log Po/w (XLOGP3) : | -0.05 |
Log Po/w (WLOGP) : | 1.59 |
Log Po/w (MLOGP) : | 1.86 |
Log Po/w (SILICOS-IT) : | 1.85 |
Consensus Log Po/w : | 1.47 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.25 |
Solubility : | 12.4 mg/ml ; 0.0566 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.35 |
Solubility : | 97.8 mg/ml ; 0.446 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.68 |
Solubility : | 0.461 mg/ml ; 0.0021 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1218096-48-0 ]
1-(2-Cyanobenzyl)piperidine-2-carboxylic acid
Similarity: 0.85
[ 18085-37-5 ]
Methyl 1-benzylazetidine-2-carboxylate
Similarity: 0.84
[ 1137664-24-4 ]
Ethyl 6-phenylpiperidine-2-carboxylate
Similarity: 0.80
[ 91641-50-8 ]
2-Morpholino-2-phenylacetic acid hydrochloride
Similarity: 0.79
[ 10315-07-8 ]
1-Benzylpiperidine-4-carboxylic acid
Similarity: 0.76
[ 54329-54-3 ]
2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
Similarity: 0.93
[ 67123-97-1 ]
1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid
Similarity: 0.89
[ 92932-74-6 ]
1,2,3,4-Tetrahydroisoquinoline-1-carboxylic acid hydrochloride
Similarity: 0.88
[ 77497-95-1 ]
(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid hydrochloride
Similarity: 0.87
[ 1218096-48-0 ]
1-(2-Cyanobenzyl)piperidine-2-carboxylic acid
Similarity: 0.85
[ 1218096-48-0 ]
1-(2-Cyanobenzyl)piperidine-2-carboxylic acid
Similarity: 0.85
[ 18085-37-5 ]
Methyl 1-benzylazetidine-2-carboxylate
Similarity: 0.84
[ 1137664-24-4 ]
Ethyl 6-phenylpiperidine-2-carboxylate
Similarity: 0.80
[ 91641-50-8 ]
2-Morpholino-2-phenylacetic acid hydrochloride
Similarity: 0.79
[ 10315-07-8 ]
1-Benzylpiperidine-4-carboxylic acid
Similarity: 0.76
[ 1218096-48-0 ]
1-(2-Cyanobenzyl)piperidine-2-carboxylic acid
Similarity: 0.85
[ 1137664-24-4 ]
Ethyl 6-phenylpiperidine-2-carboxylate
Similarity: 0.80
[ 10315-07-8 ]
1-Benzylpiperidine-4-carboxylic acid
Similarity: 0.76
[ 41447-18-1 ]
(S)-1-Methylpiperidine-2-carboxylic acid
Similarity: 0.75
[ 41447-17-0 ]
(R)-1-Methylpiperidine-2-carboxylic acid
Similarity: 0.75